Sanofi halts venglustat clinical programme in ADPKD
1st June 2021 Uncategorised 0Phase II/III trial of the drug did not meet its futility criteria of the annualised rate change in total kidney volume (TKV) More: Sanofi halts venglustat clinical programme in ADPKD Source: News
read more